Advertisement

Classical Swine Fever Virus

  • Han Sang Yoo
Chapter

Abstract

Classical swine fever (CSF) caused by classical swine fever virus (CSFV), Pestivirus genus of the Flavivirdae family, is a highly contagious, multisystemic, and hemorrhagic disease of pigs and one of the most important disease in pig industry, economically and clinically. Domestic and wild pigs are the only natural reservoirs of CSFV. Since the first report of the outbreak of CSF in the early 19th century, a lot of attempts have been made to prevent and/or eradicate the disease. Many countries have successfully eradicated CSF due to the attempts and trials. However, some countries are still sporadic outbreak and/or endemic. Therefore, World Organization for Animal Health is still designated as a notifiable disease. As a step to prevent and/or eradicate the disease, vaccines have been developed. After reviewing etiology, clinical symptoms and diagnosis of CSF, development of vaccines, especially recent vaccines were intensively reviewed. Researches on plant-made vaccine candidates against CSF were introduced in this chapter.

Keywords

Classical swine fever virus Vaccines Plant Prevention 

References

  1. Andrew M, Morris K, Coupar B, Spoat K, Oke P, Bruce M, Broadway M, Morrissy C, Strom D (2006) Porcine interleukin-3 enhances DNA vaccination against classical swine fever. Vaccine 24:3241–3247.  https://doi.org/10.1016/j.vaccine.2006.01.023CrossRefPubMedGoogle Scholar
  2. Barrera M, Sanchez O, Farnos O, Rodriguez MP, Dominguez P, Tait H, Frias M, Avila M, Vega E, Toledo JR (2010) Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats. Vet Immunol Immunopath 133:25–32.  https://doi.org/10.1016/j.vetimm.2009.06.015CrossRefGoogle Scholar
  3. Beer M, Reimann I, Hoffmann B, Depner K (2007) Novel marker vaccines against classical swine fever. Vaccine 25:5665–5670.  https://doi.org/10.1016/j.vaccine.2006.12.036CrossRefPubMedGoogle Scholar
  4. Blome S, Gabriel C, Schmeiser S, Meyer D, Meindl-Bohmer A, Koenen F, Beer M (2014) Efficacy of marker vaccine candidate CP7_E2alf against challenege with classical swine fever virus isolates of different genotypes. Vet Microbiol 169:8–17.  https://doi.org/10.1016/j.vetmic.2013.12.002CrossRefPubMedGoogle Scholar
  5. Blome S, Moβ C, Reimann I, Konig P, Beer M (2017a) Classical swine fever vaccines—State-of-the-art. Vet Microbiol 206:10–20.  https://doi.org/10.1016/j.vetmic.2017.01.001CrossRefPubMedGoogle Scholar
  6. Blome S, Staubach C, Henke J, Carlson J, Beer M (2017b) Classical swine fever—An updated review. Viruses 9:86.  https://doi.org/10.3390/v9040086CrossRefPubMedCentralGoogle Scholar
  7. Bounna A, de Smit AJ, de Kluijver EP, Terpstra C, Moormann RJ (1999) Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever. Vet Microbiol 66:101–114CrossRefGoogle Scholar
  8. Dong XN, Chen YH (2007) Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25:205–230.  https://doi.org/10.1016/j.vaccine.2006.07.033CrossRefPubMedGoogle Scholar
  9. Dong XN, Qi Y, Ying J, Chen X, Chen YH (2006) Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinat on E2. Vaccine 24:426–434.  https://doi.org/10.1016/j.vaccine.2005.08.002CrossRefPubMedGoogle Scholar
  10. Dong XN, Wei K, Liu ZQ, Chen YH (2002) Candidate peptide vaccine induced protection against classical swine fever virus. Vaccine 21:167–173CrossRefPubMedGoogle Scholar
  11. Eble PL, Quak S, Geurtus Y, Moonen-Leusen HWM, Loeffen WLA (2014) Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies. Vet Microbiol 174:27–38. https://doi.org/10.016/j.vetmic.2014.08.030CrossRefPubMedGoogle Scholar
  12. Edwards S (2000) Survival and inactivation of classical swine fever virus. Vet Microbiol 73:175–181CrossRefPubMedGoogle Scholar
  13. Edwards S, Fukusho A, Lefevre P, Lipowski A, Pejsak Z, Roehe P, Westergaard J (2000) classical swine fever: the global situation. Vet Microbiol 73:103–119CrossRefPubMedGoogle Scholar
  14. Elbers AR, Stegeman JA, de Jong MC (2001) Factors associated with the introduction of classical swine fever virus into pig herds in the central area of the 1997/98 epidemic in The Netherlands. Vet Rec 149(13):377–382CrossRefPubMedGoogle Scholar
  15. Floegel-Niesmann G, Blome S, Gerβ-Dulmer H, Bunzenthal C, Moennig V (2009) Virulence of classical swine fever virus isolates from Europe and other areas during 1996 until 2007. Vet Microbiol 139:165–169CrossRefPubMedGoogle Scholar
  16. Frizemeier J, Teufferet J, Greiser-Wilke I, Staubach Ch, Schiuter H, Moenning V (2000) Epidemiologu of classical swine fever in Germany in the 1990s. Vet Microbiol 77:29–41CrossRefGoogle Scholar
  17. Frey CF, Bauhofer O, Ruggli N, Summerfield A, Hofmann MA, Tratschin JD (2006) Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application. Vet Res 37:655–670.  https://doi.org/10.1051/vetres:2006028CrossRefPubMedGoogle Scholar
  18. Ganges L, Barrera M, Nunez JI, Blanco I, Frias MT, rodriguez F, Sobrino F (2005) A DNA vaccine expressing E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Vaccine 24: 3741–3752.  https://doi.org/10.1016/j.vaccine.2005.01.153CrossRefPubMedGoogle Scholar
  19. Goller KV, Dräger C, Höper D, Beer M, Blome S (2015) classical swine fever virus m, arker vaccine strain CP7_E2alf: genetic stability in vitro and in vivo. Arch Virol 160:3121–3125.  https://doi.org/10.1007/s00705-015-2611-zCrossRefPubMedGoogle Scholar
  20. Gomez E, Zoth SC, Carrillo E, Roux ME, Berinstein A (2008) Mucosal immunity induced by orally administered transgenic plants. Immunobiology 213:671–675.  https://doi.org/10.1016/j.imbio.2008.02.002CrossRefPubMedPubMedCentralGoogle Scholar
  21. Hoffmann B, Beer M, Reid SM, Mertens P, Oura CAL, van Rijn PA, Slomka MJ, Banks J, Brown IH, Alexander DJ, King DP (2009) A review of RT-PCR technologies used in veterinary virology and disease control: sensitive and specific diagnosis of five livestock diseases notifiable to the World Organisation for Animal Health. Vet Microbiol 139:1–23.  https://doi.org/10.1016/j.vetmic.2009.04.034CrossRefPubMedGoogle Scholar
  22. Hua RH, Huo H, Li YN, Xue Y, Wang XL, Guo IP, Zhou B, Song Y, Bu ZG (2014) Generation and efficacy evaluation of recombinant classical swine fever virus E2 glycoprotein expressed in stable transgenic mmalian cell line. PLoS One 9:e106891. doi; https://doi.org/10.1371/journal.pone.0106891CrossRefPubMedPubMedCentralGoogle Scholar
  23. Hulst MM, Westra DF, Wensvoort G, Moormann RJ (1993) Glycoprotein E1 of hog cholera virus expression in insect cells protects swine from hog cholera. J Virol 67:5435–5442PubMedPubMedCentralGoogle Scholar
  24. Jung MH, Shin YJ, Kim J, Cha SB, Lee WJ, Shin MK, Shin SW, Yang MS, Jang YS, Kwon TH, Yoo HS (2014) Induction of immune response in mice and pigs by oral administration of classical swine fever virus E2 protein expressed in rice calli. Arch Virol 159:3219–3230.  https://doi.org/10.1007/s00705-014-2182-4CrossRefPubMedGoogle Scholar
  25. Kirkland PD, Le Portier M, Vannier P, Finlaisom D (2012) Classical swine fever (Hog Cholera). In: Zimmerman J (ed) Diseases of Swine, 10th edn. Wiley-Blackwell, Ames, pp 539–546Google Scholar
  26. Laddomada A (2000) Incidence and control of CSF in wild boar in Europe. Vet Microboil 73:121–130CrossRefGoogle Scholar
  27. Le Dimna M, Vrancken R, Koenen F, Bougeard S, Mesplede A, Hutet E, Kuntz-Simon G, Le Potier MF (2008) Validation of two commercial real-time RT-PCR kits for rapid and specific diagnosis of classical swine fever virus. J Vriol Methods 157:136–142.  https://doi.org/10.1016/j.jvirmet.2007.08.013CrossRefGoogle Scholar
  28. Legocki AB, Miedzinska K, Czaplinska M, Plucieniczak A, Wedrychowicz H (2005) Immunoprotective properties of transgenic plants expressing E2 glycoprotein from CSFV and cysteine protease from Fascioloa hepatica. Vaccine 23:1844–1846.  https://doi.org/10.1016/j.vaccine.2004.11.015CrossRefPubMedGoogle Scholar
  29. Leifer I, Dpner K, Blome S, Le Potier MF, Le Dimna M, Beer M, Hoffmann B (2009) Differentiation of C-strain Riems or CP7_E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR. J Virol Methods 158:114–122.  https://doi.org/10.1016/j.virolmet.2009.02.002CrossRefPubMedGoogle Scholar
  30. Li H, Gao R, Zhang Y (2016) A promsing trigene recombinant human adenovirus vaccine against classical swine fever virus. Viral Immunol 29(4):244–251.  https://doi.org/10.1089/vim.2015.0068CrossRefPubMedGoogle Scholar
  31. Li N, Qiu HJ, Zhao JJ, Li Y, Wang MJ, Lu BW, Han CG, Hou Q, Wang ZH, Gao H, Peng WP, Li GX, Zhu QH, Tong GZ (2007a) A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Vaccine 25:2907–2912.  https://doi.org/10.1016/j.vaccine.2006.08.020CrossRefPubMedGoogle Scholar
  32. Li N, Zhao JJ, Zhao HP, Sun Y, Zhu QH, Tong GZ, Qiu HJ (2007b) Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus. J Virol Methods 144:73–78.  https://doi.org/10.1016/j.jviromet.2007.03.018CrossRefPubMedGoogle Scholar
  33. Lim SI, Jeoung HY, Kim B, Song JY, Kim JJ, Kim HY, Cho IS, Kim B, Woo GH, Lee JB, An DJ (2016a) Impact of porcine reproductive and respiratory syndrome virus and porcine circovirus-2 infection on the potency of the classical swine fever vaccine (LOM strain). Vet Microbiol 193:36–41.  https://doi.org/10.1016/j.vetmic.2016.07.027CrossRefPubMedGoogle Scholar
  34. Lim SI, Song JY, Kim JJ, Hyun BH, Kim HY, Cho IS, Kim B, Woo GH, Lee JB, An DJ (2016b) Safety of classical swine fever virus vaccine strain LOM in pregnant sows and their offspring. Vaccine 34:2021–2026.  https://doi.org/10.1016/j.vaccine.2016.02.062CrossRefPubMedGoogle Scholar
  35. Lin GJ, Deng MC, Chen ZW, Liu TY, Wu CW, Cheng CY, Chien MS, Huang C (2012) Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission. Vaccine 30:2336–2341.  https://doi.org/10.1016/j.vaccine.2012.01.051CrossRefPubMedGoogle Scholar
  36. Liu I, Hoffmann B, Baule C, Beer M, Belak S, Widen F (2009) Two real-time RT-PCR assays of classical swine fever virus developed for the genetic differentiation of naturally infected from vaccinated wild boars. J Virol Methods 159:131–133.  https://doi.org/10.1016/j.jviromet.2009.03.003CrossRefPubMedGoogle Scholar
  37. Liu S, Yu X, Wang C, Wu J, Kong X, Tu C (2006) Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus. Vaccine 24:7175–7180.  https://doi.org/10.1016/j.vaccine.2006.06.042CrossRefPubMedGoogle Scholar
  38. MacLachlan NJ, Dubovi EJ (ed) (2011) Classical swine fever virus. In: Fenner’s veterinary virology, 4th ed. Elsevier, Tokyo, p 480–481Google Scholar
  39. Madera R, Gong W, Wang L, Burakova Y, Lleellish K, Galliher-Beckley A, Nietfeld J, Henningson J, Jia K, Li P, Bai J, Schlup J, McVey S, Tu C, Shi J (2016) Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge. BMC Vet Res 12:197.  https://doi.org/10.1186/s12917-016-0823-4CrossRefPubMedPubMedCentralGoogle Scholar
  40. Marconi G, Albertini E, Barone P, De Marchis F, Lico C, Marusic C, Rutili D, Veronesi F, Porceddu A (2006) In planta production of two peptides of the classical swine fever virus (CSFV) E2 glycoprotein fused the coat protein of potato virus X. BMC Biotech 6:29.  https://doi.org/10.1186/1472-6750-6-29CrossRefGoogle Scholar
  41. Maurer R, Stettler P, Ruggli N, Hofmann MA, Tratschin JD (2005) Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Vaccine 23:3318–3328.  https://doi.org/10.1016/j.vaccine.2005.01.076CrossRefPubMedGoogle Scholar
  42. Meyers G, Rumenapf T, Thiel HJ (1989) Molecular cloning and nucleotide sequence of the genome of hog cholera virus. Virology 171:555–567.  https://doi.org/10.1016/0042-6822(89)90625-9CrossRefPubMedGoogle Scholar
  43. Meyers G, Tautz N, Becher P, Thiel HJ, Kummerer BM (1997) Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. J Virol 71:1735PubMedPubMedCentralGoogle Scholar
  44. Meyers G, Thiel HJ, Rümenapf T (1996) Classical swine fever virus: recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles. J Virol 70:1588–1595PubMedPubMedCentralGoogle Scholar
  45. Meyers G, Thiel HJ (1996) Molecular characterization of pestiviruses. Adv Virus Res 47:53–118CrossRefPubMedGoogle Scholar
  46. Milicevic V, Dietze K, Plavsic B, Tikvicki M, Pinto J, Depner K (2013) Oral vaccination of backyard pigs against classical swine fever. Vet Microbiol 163:167–171.  https://doi.org/10.1016/j.vetmic.2012.12.005CrossRefPubMedGoogle Scholar
  47. Moenning V, Becher P (2015) Pestivirus control programs: how far have we come and where are we going? Anim Health Res Rev 16(1):83–87.  https://doi.org/10.1017/S1466252315000092CrossRefGoogle Scholar
  48. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci USA 104:10986–10991.  https://doi.org/10.1073/pnas.0703766104CrossRefPubMedGoogle Scholar
  49. Paton DJ, McGoldrick A, Greiser-Wilke I, Parchariyanon S, Sing JY, Liou PP, Stadejek T, Lowings JP, Bjorklund H, Belak S (2000) Genetic typing of classical swine fever virus. Vet Microbiol 73:137–157CrossRefPubMedGoogle Scholar
  50. Plateau E, Vannier P, Tillon JP (1980) Atypical hog cholera infection: viral isolation and clinical study of in utero transmission. Am J Vet Res 41:2012–2015PubMedGoogle Scholar
  51. Rau H, Revets H, Balmelli C, McCullough KC, Summerfield A (2006) Immunological proeprties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Vet Res 37:155–168. https://doi.org/10.051/vetres:2005049CrossRefPubMedGoogle Scholar
  52. Ribbens S, DEwulf J, Koenen F, Laevens H, de Kruif A (2004) Transmission of classical swine fever. A review. Vet Q 26:146–155CrossRefPubMedGoogle Scholar
  53. Rossi S, Staubach C, Blome S, Guberti V, Thulke HH, Vos A, Koenen F, Le Potier M (2015) Controlling of CSFV in European wild boar using oral vaccination: a review. Front Micorbiol 6:1141. https://doi.org/10.3389/fmicb.2015.01141CrossRefGoogle Scholar
  54. Rumennapf T, Stark R, Meyers G, Thiel HJ (1991) Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 65:589–597Google Scholar
  55. Sanchez O, Barrera M, Farnos O, Parra NC, Salgado ER, Saavedra PA, Meza CD, Rivas CI, Cortez-San Martin M, Toledo JR (2014) Effectiveness of the E2-classcial swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats. Clin Vac Immunol 21(12):1628–1634.  https://doi.org/10.1128/CVI.00416-14CrossRefGoogle Scholar
  56. Saulmon EE (1973) Hog cholera eradication? Dream or reality. J Am Vet Med Assoc 163:1103–1105PubMedGoogle Scholar
  57. Shao HB, He DM, Qian KX, Shen GF, Su ZL (2008) The expression of classical swine fever virus structural protein E2 gene in tobacco chloroplasts for applying chloroplasts as bioreactors. Mol Biol Gene 331:179–184.  https://doi.org/10.1016/j.crvi.2007.12.007CrossRefGoogle Scholar
  58. Shahid N, Daniell H (2016) Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotech J 14:2079–2099.  https://doi.org/10.1111/pbi.12604CrossRefGoogle Scholar
  59. Song JY, Lim SI, Jeoung HY, Choi EJ, Hyun BH, Kim B, Kim J, Shin YK, dela Pena RC, Kim JB, Joo H, An DJ (2013) Prevalence of classical swine fever virus in domestic pigs in South Korea: 1999–2011. Trans Emer Dis 60:546–551.  https://doi.org/10.1111/j.1865-1682.2012.0137.xCrossRefPubMedGoogle Scholar
  60. Streatfied S (2006) Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150–157.  https://doi.org/10.1016/j.ymeth.2005.09.013CrossRefGoogle Scholar
  61. Sun Y, Li HY, Tian DY, Han QY, Zhang X, Li N, Qiu HJ (2011) A novel alphavurys replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Vaccine 29:8364–8372.  https://doi.org/10.1016/j.vaccine.2011.08.085CrossRefPubMedGoogle Scholar
  62. Sun Y, Tian DY, Li S, Meng QL, Zhao BB, Li Y, Li D, Ling LJ, Liao YJ, Qiu HJ (2013) Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever. Vaccine 31:538–544.  https://doi.org/10.1016/j.vaccine.2012.11.013CrossRefPubMedGoogle Scholar
  63. Tarradas J, Argilague JM, Rosell R, Nofrarias M, Crisci E, Cordoba L, Perez-Martin E, Diaz I, Rodriguez F, Domingo M, Montoya M, Ganges L (2010) Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. Vet Microbiol 142:51–58.  https://doi.org/10.1016/j.vetmic.2009.09.043CrossRefPubMedGoogle Scholar
  64. Toledo JR, Sanchez O, Montesino R, Farnos O, Rodriguez MP, Alfonso P, Oramas N, Rodriguez E, Santana E, Vega E, Ganges L, Frias MT, Cremata J, Barrera M (2008) Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats. J Biotechnol 133:370–376.  https://doi.org/10.1016/j.jbiotec.2007.09.014CrossRefPubMedGoogle Scholar
  65. van Gennip HGP, Bouma A, van Rijn PA, Widjojoatmodjo MN, Moormann RJM (2002) Experimental non-transmissible marker vaccine for classical swine fever (CSF) by transcomplementation of Erns or E2 of CSFV. Vaccine 20:1544–1556.  https://doi.org/10.1016/S0264-410X(01)00497-2CrossRefPubMedGoogle Scholar
  66. van Oirschot JT (2003) Vaccinology of classical swine fever: from lab to field. Vet Microbiol 96:367–384.  https://doi.org/10.1016/j.vetmic.2003.09.008CrossRefPubMedGoogle Scholar
  67. Vannier P, Plateau E, Tillon JP (1981) Congenital tremor in pigs farrowed from sows-given hog cholera virus during pregnancy. Am J Vet Res 42:135–137PubMedGoogle Scholar
  68. Villena J, Salva S, Aguero G, Alvarez S (2011) Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol 55:434–445. https://doi.org/10.111/j.1348-0421.2011.00334xCrossRefPubMedGoogle Scholar
  69. Wienhold D, Armengol E, Marquardt C, Voigt H, Buttner M, Saalmuller A, Pfaff E (2005) Immunomodulatory effect of plasmid co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination. Vet Res 36:571–587.  https://doi.org/10.1051/vetres:2005019CrossRefPubMedGoogle Scholar
  70. Wu CM, Hsuan SL, Chen ZW, Jinn TR, Huang C, Liao JW, Chen TH, Liao CM, Lee WC, Wu TY, Chien MS (2010) Expression and immunological studies of classical swine fever virus glycoprotein E2 in the bi-cistronic baculovirus/larvae expression system. Biosci Biotechnol Biochem 74(7):1343–1349.  https://doi.org/10.1271/bbb.90894CrossRefPubMedGoogle Scholar
  71. Xia SL, Xiang GT, Lei JL, Du M, Wang Y, Zhou M, Liu Y, Ji S, Wang YL, Luo Y, Sun Y, Qiu HJ (2016a) Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain. Vet Microbiol 196:50–54.  https://doi.org/10.1016/j.vetmic.2016.10.001CrossRefPubMedGoogle Scholar
  72. Xia SL, Lei JL, Du M, Wang Y, Cong X, Xiang GT, Li LF, Yu S, Du E, Liu S, Sun Y, Qiu HJ (2016b) Enhanced protective immunity of the chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever in pigs by a Salmonella bacterial ghost adjuvant. Vet Res 47:64.  https://doi.org/10.1186/s13567-016-0346-9CrossRefPubMedPubMedCentralGoogle Scholar
  73. Xu YG, Cui LC, Tian CY, Zhang GC, Huo GC, Tang LJ, Li YJ (2011) Immunogenicity of recombinant classical swine fever virus CD8+ T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination. Clin Vaccine Immunol 18:1979–1986.  https://doi.org/10.1128/CVI.05204-11CrossRefPubMedPubMedCentralGoogle Scholar
  74. Xu YG, Guan XT, Liu ZM, Tian CY, Cui LC (2015) Immunogenicity in swine of orally administered recombinant Lactobacillus plantarum expressing classical swine fever virus E2 protein in conjunction with thymosin α-1 as an adjuvant. Appl Environ Micorbiol 81(11):3745–3752.  https://doi.org/10.1128/AEM.00127-15CrossRefGoogle Scholar
  75. Yuki Y, Tokuhara D, Nochi T, Yasuda H, Mejima M, Kurokawa S, Takahashi Y, Kataoka N, Nakanishi U, Hagiwara Y, Fujihashi K, Takaiwa F, Kiyono H (2009) Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity. Vaccine 27:5982–5988.  https://doi.org/10.1016/j.vaccine.2009.07.071CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Infectious Diseases, College of Veterinary MedicineSeoul National UniversitySeoulKorea

Personalised recommendations